Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
story of the week
Published in and
2 other channels

Journal Scan / Research · {not yet published}

Effects of GLP-1 Receptor Agonists on Kidney and Cardiovascular Disease Outcomes

The Lancet Diabetes & Endocrinology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Silvio Inzucchi MD

The Lancet Diabetes & Endocrinology
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Lancet Diabetes Endocrinol 2024 Nov 25;[EPub Ahead of Print], SV Badve, A Bilal, MMY Lee, N Sattar, HC Gerstein, CT Ruff, JJV McMurray, P Rossing, G Bakris, KW Mahaffey, JFE Mann, HM Colhoun, KR Tuttle, RE Pratley, V Perkovic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.